Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 584
Filtrar
1.
BMJ Case Rep ; 17(7)2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38955384

RESUMEN

Camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP) is a rare autosomal recessive disease caused by mutation in proteoglycan 4 (PRG4) gene on chromosome 1q25-q31. We faced a dilemma and delay in diagnosis in two sisters. The elder sister had pericardial effusion with constrictive pericarditis, underwent pericardiectomy and received empirical treatment for suspected tuberculosis. After 2 years, she developed bilateral knee swelling with restriction of movement. At the same time, her younger sister also presented with bilateral knee swelling which aroused the suspicion of genetic disease. The whole-genome sequencing revealed homozygous PRG4 mutation suggestive of CACP syndrome.


Asunto(s)
Coxa Vara , Humanos , Femenino , Coxa Vara/diagnóstico , Proteoglicanos/genética , Deformidades Congénitas de la Mano/genética , Deformidades Congénitas de la Mano/diagnóstico , Artropatía Neurógena/genética , Artropatía Neurógena/diagnóstico , Derrame Pericárdico/diagnóstico , Deformidades Congénitas de las Extremidades Superiores/genética , Deformidades Congénitas de las Extremidades Superiores/diagnóstico , Deformidades Congénitas de las Extremidades Superiores/complicaciones , Pericarditis Constrictiva/diagnóstico , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/cirugía , Deformidades Congénitas de las Extremidades Inferiores/genética , Deformidades Congénitas de las Extremidades Inferiores/diagnóstico , Pericardiectomía , Mutación , Diagnóstico Diferencial , Sinovitis
2.
J Clin Ultrasound ; 52(5): 529-534, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38476017

RESUMEN

PURPOSE: To analyze ultrasound features of cervical thoracic duct for patients with constrictive pericarditis and chylothorax. METHODS: Patients were retrospectively assessed. The patients were divided into a non-pleural effusion (PE) group (n = 54), a chylothorax group (n = 23), and non-chylothorax group (n = 28). Conventional ultrasound was used to obtain the maximum inner diameter and collapse of the inferior vena cava, the inner diameter of left cervical thoracic duct, and the frequency of opening of the valve at the end of the left thoracic duct. Contrast ultrasonography was used to score the reverse flow of the thoracic tube. RESULTS: The percentage of PE was 48.5%, and the percentage of chylothorax was 21.9%. The three groups had significant differences in five parameters. The inner diameter of left cervical thoracic duct was correlated with the degree of central venous pressure. Contrast ultrasonography was effective in quantitative assessment of the degree of intravenous-thoracic cord reverse flow which correlated with all parameters of central venous pressure. CONCLUSION: Thoracic duct dilation and regurgitation secondary to central venous pressure can lead to chyloreflux disorder and may be the mechanism of chylothorax occurrence in constrictive pericarditis.


Asunto(s)
Quilotórax , Pericarditis Constrictiva , Conducto Torácico , Ultrasonografía , Humanos , Pericarditis Constrictiva/diagnóstico por imagen , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/fisiopatología , Conducto Torácico/diagnóstico por imagen , Quilotórax/diagnóstico por imagen , Masculino , Estudios Retrospectivos , Femenino , Persona de Mediana Edad , Anciano , Ultrasonografía/métodos , Adulto
3.
ESC Heart Fail ; 11(3): 1785-1789, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38318721

RESUMEN

Constrictive pericarditis is a rare disease. Localized constrictive pericarditis leading to bilateral pleural effusion is more difficult to recognize, and the diagnostic procedure can be ambiguous. Here, we report two patients diagnosed with localized constrictive pericarditis who presented with bilateral pleural effusion. A thorough work-up showed that the pleural effusion was nonspecific, as was the pathology of the pleura. One patient had a history of pericardial effusion 2 years ago, and the other had undergone surgery for an anterior mediastinum teratoma. Pericardial scarring was found on their chest CT scans. The patients underwent pericardiectomy, and localized pericardial thickening was excised. The bilateral pleural effusion was effectively cured, and the patients showed satisfactory recovery on follow-up. Physicians should be aware of localized pericarditis leading to bilateral pleural effusion, and pericardiectomy is an effective diagnostic and therapeutic procedure.


Asunto(s)
Pericardiectomía , Pericarditis Constrictiva , Derrame Pleural , Tomografía Computarizada por Rayos X , Humanos , Pericarditis Constrictiva/diagnóstico , Pericarditis Constrictiva/cirugía , Pericarditis Constrictiva/complicaciones , Masculino , Pericardiectomía/métodos , Derrame Pleural/diagnóstico , Derrame Pleural/etiología , Persona de Mediana Edad , Femenino , Ecocardiografía , Adulto , Diagnóstico Diferencial
4.
Nat Rev Dis Primers ; 9(1): 36, 2023 07 20.
Artículo en Inglés | MEDLINE | ID: mdl-37474539

RESUMEN

Cardiac tamponade is a medical emergency caused by the progressive accumulation of pericardial fluid (effusion), blood, pus or air in the pericardium, compressing the heart chambers and leading to haemodynamic compromise, circulatory shock, cardiac arrest and death. Pericardial diseases of any aetiology as well as complications of interventional and surgical procedures or chest trauma can cause cardiac tamponade. Tamponade can be precipitated in patients with pericardial effusion by dehydration or exposure to certain medications, particularly vasodilators or intravenous diuretics. Key clinical findings in patients with cardiac tamponade are hypotension, increased jugular venous pressure and distant heart sounds (Beck triad). Dyspnoea can progress to orthopnoea (with no rales on lung auscultation) accompanied by weakness, fatigue, tachycardia and oliguria. In tamponade caused by acute pericarditis, the patient can experience fever and typical chest pain increasing on inspiration and radiating to the trapezius ridge. Generally, cardiac tamponade is a clinical diagnosis that can be confirmed using various imaging modalities, principally echocardiography. Cardiac tamponade is preferably resolved by echocardiography-guided pericardiocentesis. In patients who have recently undergone cardiac surgery and in those with neoplastic infiltration, effusive-constrictive pericarditis, or loculated effusions, fluoroscopic guidance can increase the feasibility and safety of the procedure. Surgical management is indicated in patients with aortic dissection, chest trauma, bleeding or purulent infection that cannot be controlled percutaneously. After pericardiocentesis or pericardiotomy, NSAIDs and colchicine can be considered to prevent recurrence and effusive-constrictive pericarditis.


Asunto(s)
Taponamiento Cardíaco , Derrame Pericárdico , Pericarditis Constrictiva , Pericarditis , Humanos , Taponamiento Cardíaco/diagnóstico , Taponamiento Cardíaco/etiología , Taponamiento Cardíaco/cirugía , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/diagnóstico , Pericarditis Constrictiva/cirugía , Derrame Pericárdico/diagnóstico , Derrame Pericárdico/etiología , Derrame Pericárdico/terapia , Pericardiocentesis/efectos adversos , Pericardiocentesis/métodos , Pericarditis/complicaciones , Pericarditis/diagnóstico , Pericarditis/cirugía
5.
Curr Probl Cardiol ; 48(9): 101796, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-37192678

RESUMEN

Calcific constrictive pericarditis is a very rare complication of systemic sclerosis. This is the first report of surgically treated calcific constrictive pericarditis in systemic sclerosis. A 53 years-old woman, affected by limited systemic sclerosis, had a diagnosis of calcific constrictive pericarditis. She had a medical history of congestive heart failure since 2022. The patient was treated with pericardiectomy. Via a median sternotomy, the pericardium was dissected and removed from the midline to the left phrenic nerve, thus freeing the heart. Three months after the pericardiectomy, there was a significant clinical improvement. The calcific evolution of chronic pericarditis is a rare complication of systemic sclerosis. This case represents, at best of our knowledge, the first report of calcific constrictive pericarditis, in systemic sclerosis, treated with pericardiectomy.


Asunto(s)
Pericarditis Constrictiva , Pericarditis , Esclerodermia Sistémica , Femenino , Humanos , Persona de Mediana Edad , Pericarditis Constrictiva/cirugía , Pericarditis Constrictiva/complicaciones , Pericardiectomía/efectos adversos , Pericardio/cirugía , Esclerodermia Sistémica/complicaciones
6.
Ann Cardiol Angeiol (Paris) ; 72(3): 101594, 2023 Jun.
Artículo en Francés | MEDLINE | ID: mdl-37060873

RESUMEN

Chronic Constrictive pericarditis (CCP) is a rare clinical entity that can pose diagnostic problems. Constrictive pericarditis is the final stage of a chronic inflammatory process characterized by fibrous thickening and calcification of the pericardium that impairs diastolic filling, reduces cardiac output, and ultimately leads to right heart failure and to atrial dilatation which can caused supravetricular arrythmia. Transthoracic echocardiography, computed tomography, and cardiac magnetic resonance imaging each can reveal severe diastolic dysfunction, increased pericardial thickness and calcifications. The gold standard for diagnosis is cardiac catheterization with analysis of intracavitary pressure curves, which are high and, in end diastole, equal in all chambers. CCP is the commun cause of recurrent heart failure. At present, idiopathic or viral pericarditis is the predominant cause of CP in the Western world, followed by postcardiotomy irritation and mediastinal irradiation. Tuberculosis is still a cause of pericarditis in developing countries and in immunosuppressed patient. We present a patient with symptomatic atrial fibrillation revealing chronic constrictive pericardis. He underwent to drug cardioversion before radical pericardiectomy and to date has made a good recovery without palpitations with a sinus rythm. The diagnosis of CP is often neglected by physicians, who usually attribute the symptoms to another disease process. This case show the difficulty in diagnosing, illustrated as well as the role of multimodality imaging and the excellent outcome of pericardiectomy for total recovery.


Asunto(s)
Fibrilación Atrial , Insuficiencia Cardíaca , Pericarditis Constrictiva , Masculino , Humanos , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/diagnóstico , Fibrilación Atrial/complicaciones , Pericardio , Ecocardiografía , Insuficiencia Cardíaca/complicaciones
8.
Cardiol Young ; 33(7): 1186-1188, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-36220353

RESUMEN

Constrictive pericarditis is rare in children and can be difficult to diagnose. It has been described in adults after sclerotherapy of oesophageal varices but not in children. We report two cases of chronic constrictive pericarditis after sclerotherapy of oesophageal varices in children with portal cavernoma. Constrictive pericarditis should be considered as a cause of refractory ascites.


Asunto(s)
Várices Esofágicas y Gástricas , Hipertensión Portal , Pericarditis Constrictiva , Adulto , Humanos , Niño , Várices Esofágicas y Gástricas/terapia , Várices Esofágicas y Gástricas/complicaciones , Escleroterapia/efectos adversos , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/diagnóstico , Hemorragia Gastrointestinal/etiología
9.
Chemotherapy ; 68(2): 115-118, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-35981518

RESUMEN

BACKGROUND: Drug-induced pericarditis is an important cause of pericarditis and if unnoticed and unmanaged can lead to constrictive pericarditis, pericardial effusion, and cardiac tamponade. OBJECTIVE: The objective of this analysis was to determine if a significant signal exists between azacitidine use and pericarditis. METHODS: A pharmacovigilance analysis was performed using the FDA Adverse Event Database. RESULTS: 48 reports of azacitidine-induced pericarditis with azacitidine as the suspect drug were identified. The most common indications for azacitidine use in the adverse event reports were myelodysplastic syndrome (48%) and acute myelogenous leukemia (27%). Physicians reported 44% of the azacitidine-induced pericarditis reports, while other health professional reported 52% of the reports. The disproportionality analysis showed a proportional reporting ratio of 5.0, χ2 of 149.8, reporting odds ratio of 5.0, and IC025 of 1.8. Literature review found 3 case reports of azacitidine-induced pericarditis. CONCLUSION: The signal between azacitidine and pericarditis was found to be statistically significant. Clinicians should be aware of the possible risk of pericarditis when prescribing azacitidine. If there is suspicion for azacitidine-induced pericarditis, clinicians should consider discontinuation of azacitidine to improve patient's symptoms and reduce the likelihood of the development of constrictive pericarditis, pericardial effusion, and cardiac tamponade.


Asunto(s)
Taponamiento Cardíaco , Derrame Pericárdico , Pericarditis Constrictiva , Pericarditis , Humanos , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/diagnóstico , Derrame Pericárdico/complicaciones , Derrame Pericárdico/diagnóstico , Taponamiento Cardíaco/etiología , Taponamiento Cardíaco/diagnóstico , Azacitidina/efectos adversos , Pericarditis/inducido químicamente , Pericarditis/complicaciones
11.
Ann Diagn Pathol ; 59: 151943, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-35588602

RESUMEN

Kohlmeier-Degos Disease is a unique thrombotic microvascular and arteriopathic vasculopathy that is highly selective in the organs it targets. It invariably involves the skin and can be a purely cutaneous process. It affects both the microvasculature and the arterial system ranging from a thrombogenic microangiopathy to a fibrointimal obliterative arteriopathy with an accompanying background of extravascular fibrosis. A potentially lethal complication of Kohlmeier-Degos disease is constrictive pericarditis and pleuritis. We present three male patients, ages 26 years, 46 years and 58 years of age with established cutaneous and gastrointestinal Kohlmeier-Degos disease who developed progressive pericarditis which in two necessitated a pericardiectomy. There are 6 other reported cases, 5 in men, with restrictive symptoms developing on average 6 years following the onset of skin disease and all with gastrointestinal involvement. Half of the patients died within one year following the diagnosis of cardiopulmonary restrictive disease. The restrictive symptoms developed within 12 months, 2 years and 11 years following the initial skin presentation. In one patient this complication developed despite receiving eculizumab, indicative that this extravascular fibrosing reaction was not complement mediated as opposed to the thrombotic microvascular component of the disease which is C5b-9 mediated. Two of the three patients had evidence of right ventricular dysfunction. Two of our patients died within 1 year of developing constrictive pericarditis due to progressive cardiopulmonary failure. A profibrogenic process resembling scleroderma was seen given the degree of smooth muscle actin staining along with a mirror image reduction in CD34 expression within the fibrotic pleura and pericardium. There was significant upregulation in type I interferon signaling in cases tested as revealed by the degree of staining for MXA, the surrogate type I interferon marker. We propose that excessive type I interferon signaling results in the influx of monocyte derived dendritic cells with subsequent transdifferentiation into potent collagen producing myofibroblasts. We believe that targeting and suppressing type I interferon signaling should be a cornerstone of early therapy in patients with Kohlmeier- Degos disease to prevent pleural and pericardial fibrosis.


Asunto(s)
Interferón Tipo I , Papulosis Atrófica Maligna , Pericarditis Constrictiva , Enfermedades de la Piel , Trombosis , Adulto , Fibrosis , Humanos , Masculino , Papulosis Atrófica Maligna/complicaciones , Persona de Mediana Edad , Pericarditis Constrictiva/complicaciones
12.
J Cardiothorac Surg ; 17(1): 59, 2022 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-35365165

RESUMEN

BACKGROUND: Degos disease, also known as malignant atrophic papulosis, is characterised by cutaneous manifestations due to chronic thrombo-obliterative vasculopathy. There have been reports of the rare late-onset Degos disease complicated by constrictive pericarditis (CP). This study reports a case of CP caused by Degos disease that developed 20 years after diagnosis. CASE PRESENTATION: A 62-year-old woman who had been taking aspirin for 20 years for Degos disease was hospitalised for worsening of heart failure. The patient was diagnosed with CP and underwent pericardiectomy. Pathological findings suggested the involvement of Degos disease. The postoperative course was uneventful, and her heart failure and Degos disease did not worsen. CONCLUSIONS: The study findings suggests that Degos disease can cause long-term CP. Aspirin effectively inhibited the progression of Degos disease, and surgical treatment was necessary when heart failure due to CP was refractory to treatment.


Asunto(s)
Papulosis Atrófica Maligna , Pericarditis Constrictiva , Aspirina/uso terapéutico , Femenino , Humanos , Papulosis Atrófica Maligna/complicaciones , Papulosis Atrófica Maligna/diagnóstico , Persona de Mediana Edad , Pericardiectomía , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/diagnóstico
13.
J Card Surg ; 37(7): 2092-2093, 2022 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-35236003

RESUMEN

We report a case of a 29-year-old man with constrictive pericarditis where CT angiography incidentally demonstrated a dual right coronary artery (RCA). The present case highlights the diagnostic criterion for dual RCA as well as the potential clinical implications of the anomaly.


Asunto(s)
Anomalías de los Vasos Coronarios , Pericarditis Constrictiva , Adulto , Angiografía por Tomografía Computarizada , Angiografía Coronaria , Anomalías de los Vasos Coronarios/complicaciones , Anomalías de los Vasos Coronarios/diagnóstico por imagen , Anomalías de los Vasos Coronarios/cirugía , Humanos , Masculino , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/diagnóstico por imagen , Pericarditis Constrictiva/cirugía
14.
J Investig Med High Impact Case Rep ; 10: 23247096221077816, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35257621

RESUMEN

Mulibrey (Muscle-Liver-Brain-Eye) Nanism syndrome is an extremely rare genetic disorder with multiorgan involvement. Constrictive pericarditis and diastolic dysfunction are the most common causes of mortality. We present a case of a patient with Mulibrey nanism syndrome who underwent pericardiectomy at 12 years old and was able to live 44 years more with relatively stable and asymptomatic diastolic congestive heart failure (CHF). This case highlights the importance of early recognition and treatment of constrictive pericarditis in these patients.


Asunto(s)
Enanismo Mulibrey , Pericarditis Constrictiva , Niño , Humanos , Enanismo Mulibrey/complicaciones , Enanismo Mulibrey/genética , Pericardiectomía/efectos adversos , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/cirugía
15.
Inquiry ; 59: 469580211064462, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35044271

RESUMEN

Chronic constrictive pericarditis (CCP) is one of the common causes of cardiogenic cirrhosis; it is rare for a patient to have both CCP and recurrent black stool, so we consider that CCP causes cardiogenic cirrhosis. Cardiogenic cirrhosis caused portal hypertension which then resulted in gastrointestinal bleeding. Herein, we report a case of a 40-year-old Chinese woman suffering from CCP who had upper gastrointestinal bleed and had to undergo emergency surgery. Two years after the emergency surgery, multiple reexaminations showed significantly improved cardiac functions, hemoglobin, and WBC levels and gastrointestinal functions.


Asunto(s)
Pericarditis Constrictiva , Adulto , Femenino , Estudios de Seguimiento , Hemorragia Gastrointestinal/complicaciones , Humanos , Cirrosis Hepática/complicaciones , Pericardiectomía/efectos adversos , Pericardiectomía/métodos , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/cirugía
16.
Int J Infect Dis ; 116: 238-240, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-35063679

RESUMEN

Coronavirus disease 2019 (COVID-19) and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are associated with cardiovascular complications. Here, we report a case of right-sided heart failure caused by constrictive pericarditis that developed after the administration of messenger ribonucleic acid (mRNA) vaccine against SARS-CoV-2. A 70-year-old woman presented with body weight gain, peripheral edema, and dyspnea on effort, which developed over a period of 1 week after the second dose of vaccine. The jugular venous pressure was high with a prominent y descent (Friedreich's sign) and paradoxical increase on inspiration (Kussmaul's sign). The results of IgM and IgG testing specific to SARS-CoV-2 spike and nucleocapsid proteins indicated the presence of mRNA vaccine-induced antibody and were not suggestive of COVID-19 infection. Echocardiography showed pericardial thickening and septal bounce of the interventricular septum. Computed tomography (CT) also showed pericardial thickening compared with the results of the previous CT scan performed 4 months earlier. A diagnosis of right-sided heart failure due to constrictive pericarditis was confirmed on the basis of pressure analysis during cardiac catheterization.


Asunto(s)
COVID-19 , Pericarditis Constrictiva , Anciano , Vacunas contra la COVID-19/efectos adversos , Femenino , Humanos , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/etiología , SARS-CoV-2 , Vacunación/efectos adversos , Vacunas Sintéticas , Vacunas de ARNm
17.
Fetal Pediatr Pathol ; 41(3): 480-485, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33103518

RESUMEN

BACKGROUND: Chronic constrictive pericarditis (CCP) is usually caused by the fibroinflammatory reaction of the visceral and parietal pericardium that encase the heart. The cause of CCP is various including tuberculosis, trauma, prior surgery, radiation, and malignancy. MATERIAL AND METHODS: We examined the pericardiectomy specimen of a case of CCP in a 17-year-old boy. RESULTS: The histopathology of the pericardium revealed pericardial ossification bony remodeling and hematopoiesis within the intertrabecular marrow spaces. No granulomatous or neoplastic etiology was identified. CONCLUSION: Idiopathic pericardial ossification can cause CCP in pediatric patients.


Asunto(s)
Pericarditis Constrictiva , Adolescente , Niño , Humanos , Masculino , Osteogénesis , Pericardiectomía/efectos adversos , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/diagnóstico , Pericardio/cirugía
19.
Intern Med ; 61(12): 1857-1861, 2022 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-34776488

RESUMEN

Patients with constrictive pericarditis (CP) typically present with symptoms related to right-sided heart failure, such as cardiac ascites. Spontaneous bacterial peritonitis (SBP) usually arises in association with ascites secondary to hepatic cirrhosis. We herein report a rare case of CP in which SBP developed due to cardiac ascites, even in the absence of cirrhosis. In this case, pericardiectomy improved both the hemodynamics and the ascites, while therapy with diuretics alone was insufficient. It is important to consider SBP in the differential diagnosis when any abdominal symptoms or an inflammatory response is found in patients with heart failure and cardiac ascites.


Asunto(s)
Ascitis Quilosa , Insuficiencia Cardíaca , Pericarditis Constrictiva , Peritonitis , Ascitis/complicaciones , Ascitis/diagnóstico por imagen , Ascitis Quilosa/complicaciones , Insuficiencia Cardíaca/complicaciones , Humanos , Cirrosis Hepática/complicaciones , Pericardiectomía/efectos adversos , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/diagnóstico por imagen , Pericarditis Constrictiva/cirugía , Peritonitis/complicaciones , Peritonitis/diagnóstico
20.
Cardiovasc Pathol ; 58: 107403, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34954072

RESUMEN

Nocardiosis commonly affects the respiratory system and is a rare cause of purulent pericarditis. Invasive nocardial infections occur more frequently in patients with immunosuppression. A misdiagnosis as tuberculosis infection is not uncommon, especially in the context of immunosuppression in high burden tuberculosis settings. The risk factors and clinical features of the two disease entities overlap substantially. Misdiagnosis may lead to a delay in appropriate treatment and may result in poor outcomes. It is important to note that these conditions may also co-exist in the same patient. We describe, to the best of our knowledge, the first case of Nocardia asiatica pericarditis in a 32-year-old man with Human Immunodeficiency Virus infection. The patient was initially diagnosed in September 2020 with a lower respiratory tract infection and pulmonary tuberculosis was suspected. A chest radiograph, performed at admission, revealed a pericardial effusion and N. asiatica was cultured from a pericardial fluid specimen that was collected 5 days following admission. Despite a good initial clinical response to a combination of trimethoprim/sulfamethoxazole and imipenem/cilastatin, the patient demised after 16 weeks of treatment. Previous reports of laboratory confirmed nocardial pericarditis are also reviewed and summarized.


Asunto(s)
Infecciones por VIH , Nocardia , Pericarditis Constrictiva , Adulto , VIH , Infecciones por VIH/complicaciones , Humanos , Masculino , Pericarditis Constrictiva/complicaciones , Pericarditis Constrictiva/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...